Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect

Diabetic Kidney Disease (DKD) is a major microvascular complication for diabetic patients and is the most common cause of chronic kidney disease (CKD) and end-stage renal disease. Antidiabetic drugs, such as metformin and canagliflozin, have been shown to exert renoprotective effects. Additionally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Corremans, Raphaëlle, Vervaet, Benjamin A., Dams, Geert, D’Haese, Patrick C., Verhulst, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219450/
https://www.ncbi.nlm.nih.gov/pubmed/37240387
http://dx.doi.org/10.3390/ijms24109043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219450/
https://www.ncbi.nlm.nih.gov/pubmed/37240387
http://dx.doi.org/10.3390/ijms24109043

Ejemplares similares